Healthcare: Diagnostic Substances

    Formally known as:
  • AVANT Immunotherapeutics
As of March 31, 2013
Closing price on 03/31/2013: $11.58
Filers who had this stock in their top 10: 0
13F Filers holding this stock: 121
Aggregate shares on 03/31/2013: 55,356,721
Aggregate shares on 12/31/2012: 35,483,023
Percent change: 56.01%
Funds creating new positions: 34
Funds Adding to an existing position: 57
Funds closing out their position: 8
Funds reducing their position: 26
View recent insider trading info

Schedule 13D and 13G filings submitted since 03/31/2013

Filing Company Date of
Filing
Total Reported
Shares Owned
Shares Reported
on 13F
SC 13G SAC CAPITAL ADVISORS LP 04/05/2013 3,931,355 3,930,709
SC 13G SAC CAPITAL ADVISORS LP 04/22/2013 4,319,837 3,930,709

13F Filers holding this stock

Quarter 1: Refresh

Changes in Holdings:

Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"